Ditans are a recently developed drug class for the treatment of acute migraine. In this Review, the authors provide an overview of ditan development, from the initial rationale to the clinical studies that led to the recent FDA approval of the first ditan.
- Dimos D. Mitsikostas
- Christian Waeber
- Michael A. Moskowitz
